[Study on drug sensitivity against Comamonas testosteroni by Kirby-Bauer disk diffusion method].
OBJECTIVE
To determine the drug resistance of Comamonas testosteroni (C. testosteroni) by the Kirby-Bauer (K-B) method without Clinical and Laboratory Standards Institute (CLSI) explanation or the minimum inhibitory concentration (MIC) method with the standard CLSI explanation to evaluate the sensitivity of K-B method in detection of C. testosteroni.


METHODS
K-B method and MIC method was used to determine the sensitivity of C. testosteroni to Piperacillin, Cefepime, Piperacillin/tazobactam, Imipenem, Meropenem, Amikacin, Gentamicin, Tobramycin, Ceftazidime and Ciprofloxacin. The interpretation standard for Pseudomonas aeruginosa was temporary used for the K-B method. The coincident rate was compared between the two methods.


RESULTS
The complete or partial coincident rate for K-B method and MIC method to detect Piperacillin and Cefepime was 97.4% or 2.6%; the complete coincidence rate to detect Piperacillin/tazobactam, Imipenem and Meropenem was 100%; the complete or partial coincident rate to detect Amikacin, Gentamicin and Tobramycin 94.7% or 5.3%; the complete or partial coincident rate to detect Ceftazidime was 97.4% or 2.6%; the complete or partial coincident rate to detect Ciprofloxacin 86.8% or 10.6%, and the full non-coincidence rate was 2.6%.


CONCLUSIONS
The results of drug sensitive test from the two methods are highly consistent. We suggest that the microbiology labs do not report the interpretive results for C. testosteroni with K-B method but report the test results.
Department of Clinical Laboratory, Yiling Hospital of Yichang City, Yichang Hubei 443100, China.
Changsheng
C
Kong
Hand Surgery, The Renhe Hospital of Sanxia University, Yichang Hubei 443000, China.
Jun
J
Chen
Department of Clinical Laboratory, Yiling Hospital of Yichang City, Yichang Hubei 443100, China.
Xiaoyan
X
Zou
Department of Clinical Laboratory, Yiling Hospital of Yichang City, Yichang Hubei 443100, China.
Yi
Y
Zhang
Department of Clinical Laboratory, Yiling Hospital of Yichang City, Yichang Hubei 443100, China.
Lingna
L
Zhu
D000900:Anti-Bacterial Agents; D000077723:Cefepime; D002511:Cephalosporins; D020604:Comamonas testosteroni; D015378:Imipenem; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives; D010878:Piperacillin; D000077725:Piperacillin, Tazobactam Drug Combination; D011550:Pseudomonas aeruginosa; D013845:Thienamycins
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D000077725:Piperacillin, Tazobactam Drug Combination; D015378:Imipenem; D000077723:Cefepime; D010397:Penicillanic Acid; D000077731:Meropenem; D010878:Piperacillin